- Research works
- 41 ▲ 67% vs 2018-21
- Citations
- 815 20.0 per fractional work
- Top-10% rate
- 13.4% all institutions 10.0%
- Open access
- 55% world 40%
- International
- 47% world 18%
Not ranked overall: Innovative Biologics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Innovative Biologics (United States) work in?
In all years, 57% of research at Innovative Biologics (United States) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (20%), Engineering (8%). It does 2.1× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 19 fields, with their numbers
- Health Sciences2357.1%
- Medicine2254.8%
- Veterinary11.4%
- Dentistry00.7%
- Health Professions00.2%
- Life Sciences1127.7%
- Physical Sciences512.4%
- Engineering38.3%
- Environmental Science12.0%
- Chemistry00.9%
- Materials Science00.5%
- Mathematics00.5%
- Computer Science00.2%
- Social Sciences12.8%
- Economics, Econometrics and Finance01.2%
- Social Sciences01.2%
- Decision Sciences00.2%
- Psychology00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.5×. Every wedge is a field page.
All 19 fields, with their numbers
- Immunology and Microbiology5.51×1 works
- Medicine3.34×10 works
- Biochemistry, Genetics and Molecular Biology3.33×3 works
- Veterinary2.00×0 works
- Dentistry1.79×0 works
- Pharmacology, Toxicology and Pharmaceutics1.54×0 works
- Mathematics1.11×0 works
- Neuroscience0.42×0 works
- Chemistry0.39×0 works
- Economics, Econometrics and Finance0.34×0 works
- Decision Sciences0.32×0 works
- Materials Science0.29×0 works
- Environmental Science0.25×0 works
- Agricultural and Biological Sciences0.23×0 works
- Health Professions0.18×0 works
- Engineering0.13×0 works
- Psychology0.13×0 works
- Social Sciences0.05×0 works
- Computer Science0.04×0 works
- Immunology and Microbiology 5.5×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Veterinary 2.0×
- Dentistry 1.8×
- Pharmacology, Toxicology and Pharmaceutics 1.5×
- Mathematics 1.1×
- Neuroscience 0.4×
- Chemistry 0.4×
- Economics, Econometrics and Finance 0.3×
- Decision Sciences 0.3×
- Materials Science 0.3×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Health Professions 0.2×
- Engineering 0.1×
- Psychology 0.1×
- Social Sciences 0.1×
- Computer Science 0.0×
Who are the top researchers at Innovative Biologics (United States)?
Ranked on the quality score, Vladimir A. Karginov lead among researchers whose main affiliation is Innovative Biologics (United States).
- 1
Vladimir A. Karginov
United States · #4,978,184 worldwide 1.1k citations · 50 works
Which keywords describe research at Innovative Biologics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Epidemiology, Regenerative Medicine, Monoclonal Antibodies, Regulatory Challenges, Stem Cell Regulation, Therapeutic Antibodies and Healthcare-Associated Infections.
- Toxins
- Matrix Metalloproteinases
- Education
- Antibody Engineering
- Total Hip Replacement
- Staphylococcus aureus
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Bone Regeneration
- Extracellular Matrix
- Antibiotic Resistance
- Risk Factors
- Immunogenicity
- Angiogenesis
- Regeneration
- Biopharmaceuticals
- Therapeutic Antibodies
- Regulatory Challenges
- Inflammation
- Clinical Trials
- Epidemiology
- Regenerative Medicine
- Monoclonal Antibodies
- Stem Cell Regulation
- Healthcare-Associated Infections
- Glycosylation
- Pathogenesis
- Biomaterials
- Mesenchymal Stem Cells
- Tumor Microenvironment
- Cancer Immunotherapy
- Recombinant Proteins
- Clinical Practice Guidelines
- Immunotherapy
- Revision Surgery
- Tissue Engineering
- Vaccine
- Clinical Management
- Fc Receptors
- Osteoarthritis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 3.3×27 topics
- Clinical Trials4▲ 17×9 topics
- Regenerative Medicine3▲ 36×5 topics
- Inflammation2▲ 2.6×12 topics
- Monoclonal Antibodies2▲ 42×3 topics
- Regulatory Challenges2▲ 68×1 topic
- Stem Cell Regulation2▲ 232×1 topic
- Therapeutic Antibodies2▲ 38×2 topics
- Healthcare-Associated Infections2▲ 39×3 topics
- Biopharmaceuticals2▲ 65×3 topics
- Glycosylation2▲ 20×3 topics
- Regeneration2▲ 23×3 topics
- Pathogenesis2▲ 7.1×6 topics
- Angiogenesis2▲ 9.2×6 topics
- Biomaterials2▲ 19×2 topics
- Immunogenicity2▲ 71×2 topics
- Mesenchymal Stem Cells2▲ 30×2 topics
- Risk Factors1▲ 3.2×6 topics
- Tumor Microenvironment1▲ 10×4 topics
- Antibiotic Resistance1▲ 7.7×4 topics
- Cancer Immunotherapy1▲ 22×3 topics
- Extracellular Matrix1▲ 13×5 topics
- Recombinant Proteins1▲ 61×2 topics
- Bone Regeneration1▲ 26×2 topics
- Clinical Practice Guidelines1▲ 4.8×3 topics
- Immune Checkpoint Blockade1▲ 49×1 topic
- Immunotherapy1▲ 4.3×4 topics
- PD-1 and PD-L11▲ 49×1 topic
- Revision Surgery1▲ 23×2 topics
- Staphylococcus aureus1▲ 35×2 topics
- Tissue Engineering1▲ 5.1×5 topics
- Total Hip Replacement1▲ 23×2 topics
- Vaccine1▲ 6.9×7 topics
- Antibody Engineering1▲ 25×1 topic
- Clinical Management1▲ 12×2 topics
- Education1▲ 1.88×2 topics
- Fc Receptors1▲ 25×1 topic
- Matrix Metalloproteinases1▲ 16×2 topics
- Osteoarthritis1▲ 20×3 topics
- Toxins1▲ 21×2 topics
Which research topics does Innovative Biologics (United States) publish most on?
By volume in 2022-now: Osteoarthritis Treatment and Mechanisms, Knee injuries and reconstruction techniques, Shoulder Injury and Treatment and Total Knee Arthroplasty Outcomes.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Osteoarthritis Treatment and Mechanisms Rheumatology 1 works
- 2 Knee injuries and reconstruction techniques Surgery 1 works
- 3 Shoulder Injury and Treatment Surgery 0 works
- 4 Total Knee Arthroplasty Outcomes Surgery 0 works
- 5 Biomedical Ethics and Regulation Physiology 0 works
- 6 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
- 7 Protein purification and stability Molecular Biology 0 works
- 8 Periodontal Regeneration and Treatments Urology 0 works
- 9 Pain Management and Treatment Anesthesiology and Pain Medicine 0 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Innovative Biologics (United States)'s research output changed?
Output in 2022-2025 was 67% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Innovative Biologics (United States) as a percentage of every work published that year, 0.000099% in 2024.
Fractional works of Innovative Biologics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Herndon
- Volkswagen Group (United States)
- Fibertek (United States)
- National Student Clearinghouse Research Center
- International Institute of Islamic Thought
- Sotera Defense Solutions (United States)
- Virginia Innovation Partnership Corporation
- D-Tech (United States)
- Model Driven Solutions (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Innovative Biologics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.